Screener
Inhibrx Biosciences, Inc. INBX Operating Lease Liability Payments Due
Operating Lease Liability Payments Due at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue.
The source filing: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0002007919-26-000027
| Line item | AS OF | AS OF |
|---|---|---|
| 2026 (9 months) | $ | $2,152 |
| 2027 | 2,941 | |
| 2028 | 1,492 | |
| Total future minimum lease payments | 6,585 | |
| Less: imputed interest | (681) | |
| Total operating lease liability | 5,904 | |
| Less: current portion of operating lease liability | (2,408) | |
| Non-current portion of operating lease liability | $ | $3,496 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Inhibrx Biosciences, Inc.'s operating lease liability payments due?
- Inhibrx Biosciences, Inc. (INBX) reported operating lease liability payments due of $6.59M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s operating lease liability payments due changed year-over-year?
- Inhibrx Biosciences, Inc.'s operating lease liability payments due decreased by 28.8% year-over-year, from $9.26M to $6.59M.
- What does operating lease liability payments due mean?
- This represents the total future cash outflows required to satisfy operating lease agreements. It reflects the company's reliance on leased assets rather than owned assets to conduct business operations. Monitoring this helps evaluate the company's operational leverage and fixed cost structure.
Ask your AI about Inhibrx Biosciences, Inc.'s operating lease liability payments due.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude